Navigation Links
Orthopaedic Surgeon Kevin Smith, MD, Joins Northwest Hospital & Medical Center and The Sports Medicine Clinic
Date:1/20/2009

SEATTLE, Jan. 20 /PRNewswire-USNewswire/ -- Northwest Hospital & Medical Center and The Sports Medicine Clinic are pleased to announce that board-certified orthopaedic surgeon, Kevin L. Smith, MD has joined the medical staff. He brings nearly fifteen years of experience with a special expertise in shoulder and elbow surgery.

Dr. Smith received his medical degree from the Southern Illinois University School of Medicine in Springfield, IL. He completed an internship in family medicine at Southern Illinois University Affiliated Hospitals, followed by a residency in orthopaedic surgery at McLaren Regional Medical Center, an affiliate of Michigan State University College of Human Medicine. Following his residency, he developed his specialization further with a fellowship in shoulder and elbow surgery at University of Washington School of Medicine in Seattle.

After completing his training, Dr. Smith spent more than a decade at the University of Washington Department of Orthopaedics and Sports Medicine as an Associate Professor active in teaching, research, patient care, and administration. He then spent three years at Group Health prior to joining Northwest Hospital.

Dr. Smith is a member of the American Academy of Orthopaedic Surgeons and the American Shoulder and Elbow Surgeons. His professional interests include treatment of patients of all ages with elbow and shoulder conditions such as arthritis, rotator cuff disease, instability, stiffness and fractures. He has lectured and published widely.

"I am proud to be part of Northwest Hospital and The Sports Medicine Clinic, as both have an impressive history of healthcare and orthopaedic surgery excellence," said Smith. "I look forward to taking an active role in growing and enhancing the orthopaedic program, and improving access to high quality care for patients in North Seattle'/>"/>

SOURCE Northwest Hospital and Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Parkinsons Disease Plays Havoc With Common Orthopaedic Conditions
2. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
3. Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education
4. Video: Communication is Key to Ease Worry about Orthopaedic Surgery
5. Renowned Iowa Orthopaedic Surgeon, John Albright, MD, Inducted into Sports Medicine Hall of Fame
6. Reknowned Orthopaedic Surgeon to be Installed as President of Sports Medicine Society
7. IOF announces 3 orthopaedic sessions at 2008 congress
8. Zimmer Announces Actions Affecting its Ohio-based Orthopaedic Surgical Products Operation
9. Study of 137 Meniscus Transplant Procedures in Patients with Arthritis is Presented to the Meniscus Transplantation Study Group at the American Academy of Orthopaedic Surgeons Annual Meeting
10. Smith & Nephew Orthopaedic Reconstruction Global Management Team Announced
11. Miss Maggie Moo and Mario Lopez Bring a Special Delivery of Valentines Day Cheer to the Children at the Santa Monica - UCLA and Orthopaedic Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets 2Health News:Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets 3Health News:Pill Could Boost Sports Performance 2Health News:Get Straight A's in Snacking with Supercharged Superfruits from Fruitaceuticals! 2Health News:'Who's Who' Weight Specialist Martin Schiff, M.D., 86, Devoting Rest of Life to Spreading Truth About Diets, Won't Accept Compensation From Anyone, Sending Complete Guide Free to All 2Health News:Liver damage in hepatitis C patients could be treated with warfarin, says study 2Health News:Liver damage in hepatitis C patients could be treated with warfarin, says study 3Health News: Freescale and Monebo Launch ECG-on-a-Chip Platform Solution to Aid Heart Monitoring : Advanced Hardware and Software Technology Designed to Enable More Efficient and Higher Quality Cardiac Care 2
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 1Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 2Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 1Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 2Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 3Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 4Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 1Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 2
Other Medicine Technology:Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 2Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 4Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 5Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 6Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial 2Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial 3Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial 4Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial 5